Treatment-free remission in CML: who, how, and why? von Mahon, Francois-Xavier

Volltext

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia von Legros, Laurence, Nicolini, Franck E., Etienne, Gabriel, Rousselot, Philippe, Rea, Delphine, Giraudier, Stéphane, Guerci‐Bresler, Agnès, Huguet, Françoise, Gardembas, Martine, Escoffre, Martine, Ianotto, Jean‐Christophe, Noël, Marie‐Pierre, Varet, Bruno R., Pagliardini, Thomas, Touitou, Irit, Morisset, Stéphane, Mahon, Francois‐Xavier

Volltext

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia von Branford, Susan, Kim, Dennis Dong Hwan, Apperley, Jane F., Eide, Christopher A., Mustjoki, Satu, Ong, S. Tiong, Nteliopoulos, Georgios, Ernst, Thomas, Chuah, Charles, Gambacorti-Passerini, Carlo, Mauro, Michael J., Druker, Brian J., Kim, Dong-Wook, Mahon, Francois-Xavier, Cortes, Jorge, Radich, Jerry P., Hochhaus, Andreas, Hughes, Timothy P.

Volltext

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib von MARIN, David, BAZEOS, Alexandra, PALIOMPEIS, Christos, LATHAM, Victoria, FORONI, Letizia, MOLIMARD, Mathieu, REID, Alistair, REZVANI, Katy, DE LAVALLADE, Hugues, GUALLAR, Cristina, GOLDMAN, John, KHORASHAD, Jamshid S, MAHON, Francois-Xavier, ELIASSON, Lina, MILOJKOVIC, Dragana, BUA, Marco, APPERLEY, Jane F, SZYDLO, Richard, DESAI, Ritti, KOZLOWSKI, Kasia

Volltext

Discontinuation of tyrosine kinase therapy in CML von Mahon, Francois-Xavier

Volltext

Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study) von Roy, Lydia, Chomel, Jean‐Claude, Guilhot, Joëlle, Guerci‐Bresler, Agnès, Escoffre‐Barbe, Martine, Giraudier, Stéphane, Charbonnier, Aude, Dubruille, Viviane, Huguet, Françoise, Johnson‐Ansah, Hyacinthe, Lenain, Pascal, Ame, Shanti, Etienne, Gabriel, Nicolini, Franck E., Rea, Delphine, Cony‐Makhoul, Pascale, Courby, Stéphane, Ianotto, Jean‐Christophe, Legros, Laurence, Machet, Antoine, Coiteux, Valérie, Hermet, Eric, Cayssials, Emilie, Bouchet, Stéphane, Mahon, Francois‐Xavier, Rousselot, Philippe, Guilhot, François

Volltext

Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy von Ibrahim, Amr R., Eliasson, Lina, Apperley, Jane F., Milojkovic, Dragana, Bua, Marco, Szydlo, Richard, Mahon, Francois-Xavier, Kozlowski, Kasia, Paliompeis, Christos, Foroni, Letizia, Khorashad, Jamshid S., Bazeos, Alex, Molimard, Mathieu, Reid, Alistair, Rezvani, Katayoun, Gerrard, Gareth, Goldman, John, Marin, David

Volltext

Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update von Hughes, Timothy P., Clementino, Nelma Cristina D., Fominykh, Mikhail, Lipton, Jeffrey H., Turkina, Anna G., Moiraghi, Elena Beatriz, Nicolini, Franck E., Takahashi, Naoto, Sacha, Tomasz, Kim, Dong-Wook, Fellague-Chebra, Rafik, Tiwari, Ranjan, Bouard, Catherine, Mahon, Francois-Xavier

Volltext

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States von Padula, William V, Larson, Richard A, Dusetzina, Stacie B, Apperley, Jane F, Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francois, Mahon, Francois-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C, Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A, Silver, Richard T, Simonsson, Bengt, Conti, Rena M

Volltext

Molecular monitoring of patients with ETV6‐PDGFRB rearrangement: Implications for therapeutic adaptation von Bidet, Audrey, Chollet, Claudine, Gardembas, Martine, Nicolini, Franck E., Genet, Philippe, Delmer, Alain, Caillot, Denis, Dulucq, Stéphanie, Mahon, Francois‐Xavier, Lippert, Eric

Volltext

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI von Richter, Johan, Lübking, Anna, Söderlund, Stina, Lotfi, Kourosh, Markevärn, Berit, Själander, Anders, Stenke, Leif, Deneberg, Stefan, Ahlstrand, Erik, Myhr-Eriksson, Kristina, Panayiotidis, Panayiotis, Gedde-Dahl, Tobias, Žáčková, Daniela, Mayer, Jiří, Olsson-Strömberg, Ulla, Mahon, Francois-Xavier, Saussele, Susanne, Hjorth-Hansen, Henrik, Koskenvesa, Perttu

Volltext

Deep molecular responses for treatment‐free remission in chronic myeloid leukemia von Dulucq, Stéphanie, Mahon, Francois‐Xavier

Volltext

Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission von Dulucq, Stephanie, Hayette, Sandrine, Cayuela, Jean-Michel, Bauduer, Frédéric, Chabane, Kaddour, Chevallier, Patrice, Cony-Makhoul, Pascale, Flandrin-Gresta, Pascale, Jeune, Caroline Le, Bris, Yannick Le, Legros, Laurence, Maisonneuve, Hervé, Roy, Lydia, Mahon, Francois-Xavier, Sloma, Ivan, Rea, Delphine, Nicolini, Franck Emmanuel

Volltext

PB1972: ASC4START: A PHASE IIIB, OPEN‐LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE von Hochhaus, Andreas, Saussele, Susanne, Mahon, Francois‐Xavier, Pilipovic, Virginia, Zhang, Yifan, Schuld, Peter, Brümmendorf, Tim H

Volltext

ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model von Nasr, Rihab R., Hmadi, Raed A., El‐Eit, Rabab M., Iskandarani, Ahmad N., Jabbour, Mark N., Zaatari, Ghazi S., Mahon, Francois‐Xavier, Pisano, Claudio C.P., Darwiche, Nadine D.

Volltext

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial von Saussele, Susanne, Richter, Johan, Guilhot, Joelle, Gruber, Franz X, Hjorth-Hansen, Henrik, Almeida, Antonio, Janssen, Jeroen J W M, Mayer, Jiri, Koskenvesa, Perttu, Panayiotidis, Panayiotis, Olsson-Strömberg, Ulla, Martinez-Lopez, Joaquin, Rousselot, Philippe, Vestergaard, Hanne, Ehrencrona, Hans, Kairisto, Veli, Machová Poláková, Katerina, Müller, Martin C, Mustjoki, Satu, Berger, Marc G, Fabarius, Alice, Hofmann, Wolf-Karsten, Hochhaus, Andreas, Pfirrmann, Markus, Mahon, Francois-Xavier, Ossenkoppele, Gert, Pagoni, Maria N., Söderlund, Stina, Escoffre-Barbe, Martine, Etienne, Gabriel, Dengler, Jolanta, Huguet, Francoise, von Bubnoff, Nikolas, Klamova, Hana, Faber, Edgar, Guilhot, Francois, Lotfi, Kourosh, Rea, Delphine, Brümmendorf, Tim H., de Greef, Gorgine E., Stenke, Leif, Nicolini, Franck E., Legros, Laurence, Burchert, Andreas, Voglova, Jaroslava, Charbonnier, Aude, Gyan, Emmanuel, Kunzmann, Volker, Westerweel, Peter E.

Volltext

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure von Hughes, Timothy P, Mauro, Michael J, Cortes, Jorge E, Minami, Hironobu, Rea, Delphine, DeAngelo, Daniel J, Breccia, Massimo, Goh, Yeow-Tee, Talpaz, Moshe, Hochhaus, Andreas, le Coutre, Philipp, Ottmann, Oliver, Heinrich, Michael C, Steegmann, Juan L, Deininger, Michael W.N, Janssen, Jeroen J.W.M, Mahon, Francois-Xavier, Minami, Yosuke, Yeung, David, Ross, David M, Tallman, Martin S, Park, Jae H, Druker, Brian J, Hynds, David, Duan, Yuyan, Meille, Christophe, Hourcade-Potelleret, Florence, Vanasse, K. Gary, Lang, Fabian, Kim, Dong-Wook

Volltext

Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta‐analysis of studie... von Dulucq, Stéphanie, Astrugue, Cyril, Etienne, Gabriel, Mahon, François‐Xavier, Benard, Antoine

Volltext

Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha von El Eit, Rabab M., Iskandarani, Ahmad N., Saliba, Jessica L., Jabbour, Mark N., Mahfouz, Rami A., Bitar, Nizar M.A., Ayoubi, Hanadi R. El, Zaatari, Ghazi S., Mahon, Francois‐Xavier, De Thé, Hugues B., Bazarbachi, Ali A., Nasr, Rihab R.

Volltext

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy? von MAHON, François-Xavier, ETIENNE, Gabriel

Volltext